What Does Relay Therapeutics Do?

Total employees269
HeadquartersCambridge
Founded2016

Relay Therapeutics, Inc. is a clinical-stage precision medicine company committed to transforming the drug discovery process. They leverage their proprietary Dynamoâ„¢ platform, which integrates advanced computational and experimental approaches, to visualize and understand protein motion. This deep understanding allows Relay Therapeutics to design and develop highly selective and targeted therapies for patients with cancer and genetic diseases who have limited treatment options. Their primary focus is on precision oncology, aiming to create medicines that can make a significant difference in patients' lives.

Where Is Relay Therapeutics's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for Relay Therapeutics' research and development, corporate operations, clinical development, and strategic leadership.

Notable Features:

Located in the vibrant Kendall Square area, known for its high concentration of biotech companies and research institutions. The facility likely features state-of-the-art laboratory spaces for drug discovery and development.

Work Culture:

Relay Therapeutics fosters a science-driven, innovative, and collaborative work environment. Employees are typically mission-focused, dedicated to advancing precision medicine and impacting patient lives.

HQ Significance:

Its location in Cambridge provides access to a rich talent pool, leading academic institutions like MIT and Harvard, and a strong network of collaborators and service providers essential for biotech innovation.

Values Reflected in HQ: The headquarters' design and location reflect Relay Therapeutics' commitment to cutting-edge science, innovation, and collaboration within the broader biotech ecosystem.

Location:

While Relay Therapeutics' primary operations are based in the United States, its clinical trials and research collaborations may extend internationally. The company engages with global partners, contract research organizations (CROs), and clinical sites in various countries to advance its pipeline of novel therapies for patients worldwide. This global reach is essential for conducting diverse clinical studies and accessing specialized expertise.

Street Address:

399 Binney Street, 2nd Floor

City:

Cambridge

State/Province:

Massachusetts

Country:

USA

Where Else Does Relay Therapeutics Operate Around the World?

Information Not Publicly Available

Address: N/A

Any additional presence would likely be for specific project-based needs, such as clinical trial site management or remote business development support, rather than full-scale office operations.

Buying Intent Signals for Relay Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Relay Therapeutics? Meet the Executive Team

As of April 2025, Relay Therapeutics' leadership includes:

Sanjiv Patel, M.D. - President and Chief Executive Officer
Don C. Bell, Ph.D. - Executive Vice President, Head of Research
Thomas C. Unger, Ph.D. - Chief Financial Officer
Maryam MyApp, M.D. - Chief Medical Officer
Ben Thorner - Chief Business Officer
Kimberly J. Smith - Chief People Officer
Paula Ragan, Ph.D. - Chief Development Officer
Pete Milligan - Chief Technical Operations Officer

Who's Investing in Relay Therapeutics?

Relay Therapeutics has been backed by several prominent investors over the years, including:

Third Rock Ventures
SoftBank Vision Fund
GV (Google Ventures)
Casdin Capital
Foresite Capital
Perceptive Advisors
EcoR1 Capital
Boxer Capital (Tavistock Group)

What Leadership Changes Has Relay Therapeutics Seen Recently?

Hire3
Exits0

Relay Therapeutics has made key appointments in the past year, notably strengthening its clinical leadership, development capabilities and board. No major executive departures have been publicly announced recently.

New Appointments:

Maryam MyApp, M.D., Dr. Maryam MyApp was appointed as Chief Medical Officer, bringing extensive experience in oncology drug development to lead Relay's clinical strategy.
Paula Ragan, Ph.D., Dr. Paula Ragan joined as Chief Development Officer to oversee the advancement of the company's pipeline.
Iain Dukes, D.Phil., Dr. Iain Dukes was appointed to the Board of Directors, contributing his significant biopharmaceutical leadership and R&D expertise.

What Technology (Tech Stack) Is Used byRelay Therapeutics?

Discover the tools Relay Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Relay Therapeutics Email Formats and Examples

Relay Therapeutics, Inc. primarily uses the email format [first_initial][last]@relaytx.com. Variations might exist but this is the most common pattern.

flast@relaytx.com

Format

jdoe@relaytx.com

Example

85%

Success rate

What's the Latest News About Relay Therapeutics?

GlobeNewswire • February 15, 2024

Relay Therapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Corporate Highlights

Relay Therapeutics announced its Q4 and full-year 2023 financial results, highlighting progress in its clinical programs, including RLY-2608 and RLY-4008, and upcoming milestones for 2024....more

GlobeNewswire • December 7, 2023

Relay Therapeutics Presents Updated Interim Clinical Data for RLY-2608 in Combination with Fulvestrant at the 2023 San Antonio Breast Cancer Symposium

Relay Therapeutics presented positive updated interim clinical data from its ongoing trial of RLY-2608, a PI3Kα inhibitor, in combination with fulvestrant for patients with PI3Kα-mutated, HR+, HER2- metastatic breast cancer....more

GlobeNewswire • October 25, 2023

Relay Therapeutics Appoints Iain Dukes, D.Phil. to its Board of Directors

Relay Therapeutics announced the appointment of Iain Dukes, D.Phil., a seasoned biopharmaceutical executive, to its Board of Directors, strengthening its strategic leadership....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Relay Therapeutics, are just a search away.